Literature DB >> 19010418

CYP2C9 polymorphism in five autochthonous population of the same geographic area (Spanish Pyrenees).

Alberto M Borobia1, Ana María López-Parra, Beatriz Tabarés, Elena Ramirez, Carlos Baeza, Eduardo Arroyo-Pardo, Antonio J Carcas.   

Abstract

OBJECTIVE: To evaluate the frequency of CYP2C9 polymorphisms in a cohort of Caucasians (Spanish Pyrenees), previously classified in autochthonous populations.
METHODS: Blood samples from 154 anonymous volunteer donors were collected. All the individuals were autochthonous to their respective populations (four grandparents born in the region): 23 from Valle de Arán (Lérida), 29 from Alto Urgel (Lérida), 32 from La Cerdaña (Gerona), 30 from Jacetania (Huesca) and 40 from Cinco Villas (Navarra). The analyses for allelic mutation, CYP2C9*2 and CYP2C9*3, were identified with Taqman Allelic Discrimination kits.
RESULTS: No statistical differences were found when allelic frequencies in the five autochthonous populations were compared. Frequency distribution of genotypic classes (wt/wt, wt/mut and mut/mut) in Alto Urgel was different from that in La Cerdaña, Cinco Villas and Jacetania samples. Comparison of Pyrenean and other European populations through exact test revealed significant differences in the distribution of genotypic classes: Alto Urgel, Barcelona, and Croatia yielded the highest significant differences. According to the exact test these populations were pooled in four groups. This classification produced a statistically significant percentage of variation explained by differences among groups (1.94%, P= 0.036), but not by differences among populations within groups (P=0.914), although most of the percentage of variance is explained by differences within populations (97.46%, P<0.001).
CONCLUSION: This study increases the evidence of intra-population genotypic variability and highlights the significant genotypic heterogeneity when different autochthonous populations are considered, despite no clear differences in allelic frequencies do exist.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19010418     DOI: 10.1016/j.phrs.2008.10.007

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  2 in total

1.  Impact of CYP2C19 and CYP2C9 gene polymorphisms on sodium valproate plasma concentration in patients with epilepsy.

Authors:  Cangsang Song; Xingde Li; Panpan Mao; Wenbing Song; Lu Liu; Yang Zhang
Journal:  Eur J Hosp Pharm       Date:  2020-08-31

2.  Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain.

Authors:  José A G Agúndez; Francisco Abad-Santos; Ana Aldea; Hortensia Alonso-Navarro; María L Bernal; Alberto M Borobia; Emma Borrás; Miguel Carballo; Alfonso Carvajal; José D García-Muñiz; Guillermo Gervasini; Félix J Jiménez-Jiménez; María I Lucena; Carmen Martínez; José A Sacristán; Inés Salado; Blanca Sinués; Jorge Vicente; Elena García-Martín
Journal:  Front Genet       Date:  2012-11-26       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.